Monday, December 11, 2023

Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA

Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

from Top Health News -- ScienceDaily https://ift.tt/udcbXlx
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ozempic may have revealed the brain’s hidden “craving center”

Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists ar...